Literature DB >> 6129272

The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations.

D G Blazer, C F Federspiel, W A Ray, W Schaffner.   

Abstract

The potential for anticholinergic toxicity due to concurrent use of medications was assessed among 5,902 continuous nursing home residents and a comparable group of ambulatory patients. During the study year nearly 60% of the nursing home residents and 23% of the ambulatory patients received drugs with anticholinergic properties. Based on recommended doses of the drugs, 565 of the nursing home patients and 413 of the ambulatory patients could have received three or more anticholinergic medications concurrently. An examination of nursing home patients receiving the most frequently prescribed antipsychotic and tricyclic antidepressant drugs concurrently revealed that physicians did not choose drugs selectively within the two classes in order to minimize the potential for anticholinergic toxicity. The findings of this study suggest that the risk of anticholinergic toxicity may be underestimated by physicians.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129272     DOI: 10.1093/geronj/38.1.31

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  32 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.

Authors:  Satabdi Chatterjee; Sandhya Mehta; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

Review 3.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

4.  The relationship between anticholinergic medications and Mini-Cog scores in older adults receiving home health care.

Authors:  Susan L Lakey; Peggy S Odegard; Travis E Sonnett; Stephen M Setter; Soo Borson
Journal:  Consult Pharm       Date:  2009-09

5.  Psychotropic drug use and cognitive rehabilitation practice for elderly patients.

Authors:  Eiji Kose; Toshiyuki Hirai; Toshiichi Seki
Journal:  Int J Clin Pharm       Date:  2018-08-21

6.  Managing anticholinergic side effects.

Authors:  Joseph A Lieberman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

7.  Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.

Authors:  Joshua Niznik; Xinhua Zhao; Tao Jiang; Joseph T Hanlon; Sherrie L Aspinall; Joshua Thorpe; Carolyn Thorpe
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 8.  Institutionalisation and drug use in older adults in the US.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 9.  The problems of anticholinergic adverse effects in older patients.

Authors:  M Feinberg
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

Review 10.  The cognitive impact of anticholinergics: a clinical review.

Authors:  Noll Campbell; Malaz Boustani; Tony Limbil; Carol Ott; Chris Fox; Ian Maidment; Cathy C Schubert; Stephanie Munger; Donna Fick; David Miller; Rajesh Gulati
Journal:  Clin Interv Aging       Date:  2009-06-09       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.